BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18554725)

  • 1. RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function.
    Werry TD; Loiacono R; Sexton PM; Christopoulos A
    Pharmacol Ther; 2008 Jul; 119(1):7-23. PubMed ID: 18554725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of serotonin-2C receptor G-protein coupling by RNA editing.
    Burns CM; Chu H; Rueter SM; Hutchinson LK; Canton H; Sanders-Bush E; Emeson RB
    Nature; 1997 May; 387(6630):303-8. PubMed ID: 9153397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-to-I editing of the 5HT2C receptor and behaviour.
    Gardiner K; Du Y
    Brief Funct Genomic Proteomic; 2006 Mar; 5(1):37-42. PubMed ID: 16769676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-to-I pre-mRNA editing of the serotonin 2C receptor: comparisons among inbred mouse strains.
    Du Y; Davisson MT; Kafadar K; Gardiner K
    Gene; 2006 Nov; 382():39-46. PubMed ID: 16904273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide.
    Schirle NT; Goodman RA; Krishnamurthy M; Beal PA
    Org Biomol Chem; 2010 Nov; 8(21):4898-904. PubMed ID: 20820662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene.
    Flomen R; Knight J; Sham P; Kerwin R; Makoff A
    Nucleic Acids Res; 2004; 32(7):2113-22. PubMed ID: 15087490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy.
    Yang W; Wang Q; Kanes SJ; Murray JM; Nishikura K
    Brain Res Mol Brain Res; 2004 Apr; 124(1):70-8. PubMed ID: 15093687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.
    Vitali P; Basyuk E; Le Meur E; Bertrand E; Muscatelli F; Cavaillé J; Huttenhofer A
    J Cell Biol; 2005 Jun; 169(5):745-53. PubMed ID: 15939761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
    Berg KA; Dunlop J; Sanchez T; Silva M; Clarke WP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1084-92. PubMed ID: 18065501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cocaine and reserpine administration on RNA editing of rat 5-HT2C receptor estimated by primer extension combined with denaturing high-performance liquid chromatography.
    Iwamoto K; Kato T
    Pharmacogenomics J; 2002; 2(5):335-40. PubMed ID: 12439740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of RNA editing of the serotonin 2C receptor (5-HT(₂C)R) ex vivo.
    Lanfranco MF; Anastasio NC; Seitz PK; Cunningham KA
    Methods Enzymol; 2010; 485():311-28. PubMed ID: 21050925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered RNA editing of serotonin 2C receptor in a rat model of depression.
    Iwamoto K; Nakatani N; Bundo M; Yoshikawa T; Kato T
    Neurosci Res; 2005 Sep; 53(1):69-76. PubMed ID: 16005997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and relative quantification of adenosine to inosine editing in serotonin 2c receptor mRNA by CE.
    Poyau A; Vincent L; Berthommé H; Paul C; Nicolas B; Pujol JF; Madjar JJ
    Electrophoresis; 2007 Aug; 28(16):2843-52. PubMed ID: 17702068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental changes in expression and self-editing of adenosine deaminase type 2 pre-mRNA and mRNA in rat brain and cultured cortical neurons.
    Hang PN; Tohda M; Matsumoto K
    Neurosci Res; 2008 Aug; 61(4):398-403. PubMed ID: 18534702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin2C receptor mRNA editing in neuropathic pain model.
    Nakae A; Nakai K; Tanaka T; Takashina M; Hagihira S; Shibata M; Ueda K; Mashimo T
    Neurosci Res; 2008 Feb; 60(2):228-31. PubMed ID: 18045717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring RNA editing of serotonin 2C receptor.
    Iwamoto K; Bundo M; Kasai K; Kato T
    Biochemistry (Mosc); 2011 Aug; 76(8):912-4. PubMed ID: 22022964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening for functional adenosine to inosine RNA editing systems.
    Pokharel S; Beal PA
    ACS Chem Biol; 2006 Dec; 1(12):761-5. PubMed ID: 17240974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an RNA element for specific coordination of A-to-I RNA editing on HTR2C pre-mRNA.
    Fukuda M; Oyama Y; Nishitarumizu A; Omura M; Nose K; Deshimaru M
    Genes Cells; 2015 Oct; 20(10):834-46. PubMed ID: 26259820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of phospholipase C activation and alternative ADAR1 and ADAR2 pre-mRNA splicing in modulating serotonin 2C-receptor editing in vivo.
    Schmauss C; Zimnisky R; Mehta M; Shapiro LP
    RNA; 2010 Sep; 16(9):1779-85. PubMed ID: 20651031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing.
    Werry TD; Stewart GD; Crouch MF; Watts A; Sexton PM; Christopoulos A
    Biochem Pharmacol; 2008 Nov; 76(10):1276-87. PubMed ID: 18812172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.